BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 26776366)

  • 1. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].
    Schnabel PA; Junker K
    Pathologe; 2014 Nov; 35(6):557-64. PubMed ID: 25366372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids.
    Koo CW; Baliff JP; Torigian DA; Litzky LA; Gefter WB; Akers SR
    AJR Am J Roentgenol; 2010 Sep; 195(3):661-8. PubMed ID: 20729444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent differentiation in neuroendocrine lung tumors.
    Brambilla E; Lantuejoul S; Sturm N
    Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in neuroendocrine lung tumors.
    Travis WD
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii65-71. PubMed ID: 20943645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?
    Marchevsky AM; Wirtschafter E; Walts AE
    Hum Pathol; 2015 Feb; 46(2):176-81. PubMed ID: 25532694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).
    Escudero AG; Zarco ER; Arjona JC; Moreno MJ; Rodríguez KG; Benítez AV; Cámpora RG
    Virchows Arch; 2016 Sep; 469(3):357-63. PubMed ID: 27300020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update of pathological diagnosis of pulmonary neuroendocrine tumor].
    Teng X; Zhao M; Lai M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):36-44. PubMed ID: 27045239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.
    Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E
    Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
    Travis WD
    Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.
    Gorshtein A; Gross DJ; Barak D; Strenov Y; Refaeli Y; Shimon I; Grozinsky-Glasberg S
    Cancer; 2012 Feb; 118(3):612-9. PubMed ID: 21751183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular alterations of neuroendocrine tumours of the lung.
    Rossi G; Bertero L; Marchiò C; Papotti M
    Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.
    Mengoli MC; Rossi G; Cavazza A; Franco R; Marino FZ; Migaldi M; Gnetti L; Silini EM; Ampollini L; Tiseo M; Lococo F; Fournel L; Spagnolo P; Cottin V; Colby TV
    Am J Surg Pathol; 2018 May; 42(5):646-655. PubMed ID: 29438170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.